Chronic obstructive pulmonary disease. Chronic obstructive: airway disease NOS lung disease NOS
Conditions
Interventions
Intervention 1: A kind of inhalation therapy with a mineral salt as an alternative treatment named halotherapy twice a day each for 30 minutes for 2-months. Intervention 2: Patients in control group
Treatment - Drugs
Placebo
A kind of inhalation therapy with a mineral salt as an alternative treatment named halotherapy twice a day each for 30 minutes for 2-months
Patients in control group use plastic contained Saltairs which have no inhaler in it actually as placebo drug.
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: COPD patients regarding GOLD criteria; Stable patients older 18 years . Exclusion criteria: History of surgery in thorax; COPD exacerbation; Unbearable complications of COPD; Huge changes in treatment regimen; Missing patients through out the study; Irregular treatment; Smoking; Exacerbation in comorbidities like CHF, CRF, etc.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The walked distance. Timepoint: two month after first visit. Method of measurement: 6MWT.;Forced vital capacity. Timepoint: two month after study beginning. Method of measurement: spirometry.;Forced expiratory volume. Timepoint: two month after study beginning. Method of measurement: spirometry.;Minute. Timepoint: 2 month after first visit. Method of measurement: 6MWD. | — |
Secondary
| Measure | Time frame |
|---|---|
| Disease manifestation. Timepoint: 2 month after first visit. Method of measurement: Asking patients.;Exacerbation rate. Timepoint: Every other month. Method of measurement: Asking patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlireza Eslaminejad
Shahid Beheshti University of Medical Sciences
Outcome results
None listed